1de Beer EL, Bottone AE, Voest E. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment[J]. Eur J Pharrnacol, 2001, 415 (1) : 1.
2Muraoka S, Miura T. Free radicals mediate cardiac toxicity induced by adriamycin [J]. Yakugaku Zasshi, 2003, 123 (10):855-866.
3Duquaine D, H irsch GA , Chak rabarti A, etal. Rap id2onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase[J]. Vasc Med, 2003, 8 (2) : 101-107.
4Wang S, Kono rev EA , Kota mraju S, etal. Doxo rubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms, intermediacy of H 2O2 and p532dependent pathways[J]. J Bio 1 Chem, 2004, 279 (24): 25535-25543.
5Fujimura L, Matsudo Y, KangM, et al. Protective role of Ndl in doxorubicin2in2duced cardiotoxicity [J]. Cardiovasc Res, 2004, 64 (2): 315-321.
6Minotti G, Recalcati S, Mo rdente A, et al. The secondary alcohol metabolite of doxorubicin irreversibly inactivates conitase iron regulatory protein 1 in cytosolic fractions from human my ocardium[J]. FA SEB J, 1998, 12 (7) : 541-552.
7Estevez MD, Wolf A, Schramm U. Effect of PSC 833, verapare iland am iodarone on adriamycin toxicity in cultured rat cardiomyocytes[J]. Toxicol In Vitro, 2000, 14 (1) : 17-23.
8Weilbach FX, Chan A, Toyka KV, et al. The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental auto immune encephalomyelitis[J]. Clin Exp Immunol, 2004, 135 (1): 49-55.
8Hrdina R, Gersl V, Klimtova 1, et al. Anthracycline-induced cardiotoxicity[ J]. Acta Medica( Hradec Kralove) ,2000,43:75-82.
9larussi D, lndolfi P,Casale F,et al. Recent advances in the prevention of anthracycline cardiotoxicity in childhood[J]. Curt Med Chem ,2001,8 : 1649-1660.
10Sromova T, Strnadova V, Hrstkova H. Monitoring cardiotoxicity of anthracyclines in children and possibilities of its prevention [ J ].Vnitr Lek ,2002,48:649-656.
